VAD044

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
227	オスラー病	1

227. オスラー病

臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05406362 (ClinicalTrials.gov)	July 18, 2022	10/5/2022	Assess Safety and Efficacy of VAD044 in HHT Patients	A Randomised, Placebo Controlled, Double Blind, Multicentre Proof of Concept Study to Assess the Saf ...	Hereditary Hemorrhagic Telangiectasia (HHT)	Drug: VAD044	Vaderis Therapeutics AG	NULL	Recruiting	18 Years	N/A	All	80	Phase 1	United States;Canada;Italy;Netherlands;Spain

First Previous1Next Last